Vaxcyte Inc (PCVX)
88.54
+0.15
(+0.17%)
USD |
NASDAQ |
Nov 22, 16:00
89.00
+0.46
(+0.52%)
After-Hours: 20:00
Vaxcyte Price to Book Value: 3.229 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 3.229 |
| November 21, 2024 | 3.224 |
| November 20, 2024 | 3.135 |
| November 19, 2024 | 3.176 |
| November 18, 2024 | 3.154 |
| November 15, 2024 | 3.167 |
| November 14, 2024 | 3.380 |
| November 13, 2024 | 3.524 |
| November 12, 2024 | 3.624 |
| November 11, 2024 | 3.780 |
| November 08, 2024 | 3.890 |
| November 07, 2024 | 3.745 |
| November 06, 2024 | 3.795 |
| November 05, 2024 | 3.923 |
| November 04, 2024 | 3.884 |
| November 01, 2024 | 3.913 |
| October 31, 2024 | 3.872 |
| October 30, 2024 | 3.863 |
| October 29, 2024 | 3.843 |
| October 28, 2024 | 4.107 |
| October 25, 2024 | 4.112 |
| October 24, 2024 | 4.089 |
| October 23, 2024 | 4.083 |
| October 22, 2024 | 4.102 |
| October 21, 2024 | 4.203 |
| Date | Value |
|---|---|
| October 18, 2024 | 4.205 |
| October 17, 2024 | 4.209 |
| October 16, 2024 | 4.294 |
| October 15, 2024 | 4.205 |
| October 14, 2024 | 4.118 |
| October 11, 2024 | 4.166 |
| October 10, 2024 | 4.063 |
| October 09, 2024 | 4.073 |
| October 08, 2024 | 4.069 |
| October 07, 2024 | 3.949 |
| October 04, 2024 | 4.052 |
| October 03, 2024 | 4.044 |
| October 02, 2024 | 4.160 |
| October 01, 2024 | 4.207 |
| September 30, 2024 | 4.160 |
| September 27, 2024 | 7.051 |
| September 26, 2024 | 6.945 |
| September 25, 2024 | 7.071 |
| September 24, 2024 | 7.208 |
| September 23, 2024 | 6.987 |
| September 20, 2024 | 7.178 |
| September 19, 2024 | 7.299 |
| September 18, 2024 | 7.263 |
| September 17, 2024 | 7.276 |
| September 16, 2024 | 7.120 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.585
Minimum
May 10 2021
13.05
Maximum
Jun 19 2020
4.491
Average
4.009
Median
Sep 29 2022
Price to Book Value Benchmarks
| Pfizer Inc | 1.575 |
| Merck & Co Inc | 5.638 |
| Embecta Corp | -- |
| Arrowhead Pharmaceuticals Inc | 6.973 |
| Dyne Therapeutics Inc | 4.282 |
Price to Book Value Related Metrics
| Price | 88.54 |
| Earnings Yield | -5.20% |
| Market Cap | 11.04B |